Animal Health

Perspective Therapeutics is testing a potent alpha-particle therapy for meningioma, the most common brain tumor, offering a new option where surgery fails.

A call for research on vaccine side effects exposes a deeper crisis: the collapse of public trust in science. Can rigorous data heal a polarized nation?

As Rise Therapeutics advances its oral drug R-2487, it’s not just developing another pill. It’s testing a radical new idea: resetting the immune system.

A burgeoning market for cervical dystonia is set for disruption. A pipeline of novel therapies, including oral options, promises to address unmet patient needs.

One year after its US launch, Pictor Holdings is gaining traction with a platform that makes complex disease testing fast, cheap, and accessible. But can its unique business model truly scale?

A breakthrough in cardiac fibrosis treatment reveals more than a new drug; it signals a systemic shift. How AI and human 'organoids' are making animal models obsolete.

Petco Love's massive adoption event is more than a feel-good story; it's a calculated response to an economic crisis forcing New Yorkers to surrender pets.

A strategic deal between epiq Animal Health and Vetirus brings a cost-effective regenerative therapy to vets, promising wider access to advanced care.

PetMed Express is set to reveal its annual performance, but a year of steep losses, internal probes, and fierce competition has set a somber stage.

New preclinical data shows RTY-406 could be a first-in-class therapy for PSC, a progressive liver disease with no effective treatments.

Vanda Pharmaceuticals' rare disease drug gets a key designation in Japan, unlocking major incentives and promising a new treatment for a severe skin disease.

A local dog walking company and Richmond's shelter created a partnership that gets nearly every participating dog a home. Here's how they did it.

For 20 years, a Bahamian resort has quietly built a conservation powerhouse. Inside its mission to rescue turtles, grow coral, and redefine tourism.

MBX Biosciences prepares for the Jefferies conference, with investors eyeing updates on its late-stage hypoparathyroidism drug and promising obesity portfolio.

French biotech TreeFrog Therapeutics isn't just replacing cells; it's implanting pre-wired networks. Their novel 3D microtissue shows faster, more extensive brain repair.

At SLAS 2026, MGI Tech unveiled intelligent platforms for proteomics and clinical automation, signaling a major push to accelerate scientific discovery.

A chilling short film and its unsettling LA ad campaign use psychological horror to challenge what we know about the products we buy, wear, and eat.

Strong glaucoma sales and disciplined spending helped Iridex narrow its quarterly loss, signaling resilience despite retina segment woes and global headwinds.

A top scientific honor for Dr. Mariano Garcia-Blanco validates a new approach to autoimmune disease, targeting a genetic trait in 50% of the population.

New research on the gut-brain axis and smarter antibiotic use is transforming veterinary medicine, moving from theory to practice for healthier pets.